The cervical biopsy was nondiagnostic despite imaging and PET suggesting aggressive disease; a targeted lumbar biopsy ...

In recent days, BeOne Medicines AG gained fresh attention as Wolfe Research initiated coverage with an Outperform rating and the company secured FDA orphan drug designation for its hepatocellular ...

A positive phase three trial result in a hard-to-treat cancer adds fresh momentum to one of AstraZeneca's most important ...

Interim data also suggested a strong trend toward improved PFS and OS when evaluating the STRIDE regimen in combination with TACE vs TACE alone.

Phase II Trial of Enfortumab Vedotin in Patients With Previously Treated Advanced Head and Neck Cancer Liver transplantation (LT) has been accepted as a cornerstone of care in hepatocellular carcinoma ...

Orphan Drug Designation is a key incentive established by the EMA to facilitate the development and authorisation of ...

Effects of soy food consumption in preventing hepatocellular carcinoma: A systematic review and meta-analysis. This is an ASCO Meeting Abstract from the 2026 ASCO Gastrointestinal Cancers Symposium.

Liver cancer is one of the world's deadliest cancers, and most cases are linked to chronic viral hepatitis. Yet scientists have lacked an animal model that faithfully recapitulates how the disease ...

OPDIVO is a prescription medicine used in combination with YERVOY as a first treatment to treat adults with cancer of the ...